School of Medicine Publications

Document Type

Article

Publication Date

1-2026

Abstract

Background: Coffin–Lowry syndrome (CLS) is a rare X-linked disorder caused by pathogenic variants in RPS6KA3, presenting with intellectual disability, distinctive facial and skeletal features, and variable systemic involvement. Advances in genomic technologies have expanded the mutation spectrum, yet genotype phenotype correlations remain incompletely understood.

Methods: We conducted a systematic review of published cases (n = 72) following PRISMA guidelines. Demographic, phenotypic, and genotypic data were extracted, standardized, and summarized using descriptive statistics. Associations between mutation type and key clinical features were assessed with Chi-square or Fisher’s exact tests. Diagnostic approaches and global distribution were also analyzed.

Results: The cohort comprised 50 males (69.4%) and 22 females (30.6%), median age 12 years (range: 1–45). Developmental delay (87.5%) and intellectual disability (66.7%) were the most frequent features, alongside musculoskeletal deformities (kyphoscoliosis 33.3%, pectus anomalies 19.4%) and neurologic involvement (SIDEs 12.5%, seizures 15.3%, spasticity 5.6%). Frameshift variants showed the strongest associations with SIDEs (35%, p = 0.009) and seizures (24%, p = 0.048), while splice-site mutations were linked to spasticity and cardiomyopathy. No consistent clustering of intellectual disability severity by mutation type was observed. Diagnostic methods varied, with most cases confirmed by sequencing approaches (e.g., Sanger, WES, next-generation sequencing panels), supplemented by array-based CNV detection. Geographically, cases were reported across Asia, Europe, and North America, with the largest clusters from China (14), USA (14), and Japan (9).

Conclusion: This systematic review highlights recurrent neurodevelopmental, neurologic, and skeletal phenotypes in CLS and delineates mutation-specific risks, particularly for SIDEs and seizures. The findings emphasize the value of comprehensive genomic testing, raise awareness of maternal germline mosaicism, and underscore the utility of reproductive technologies such as PGT-A/M for at-risk families. Beyond clinical and research implications, this work provides an accessible reference for affected families seeking clearer prognostic insights.

Systematic Review Registration: Identifier CRD420223404871.

Comments

Copyright © 2026 Maity, Montion, Boothe, Attarpour, Mageto, Agarwal, Patel, Lark, Cardona Valentin, Quinones-Budel, Shireen, Gadad, Anand, Goyal, Mendoza, Nauhria and Nauhria. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Publication Title

Frontiers in Genetics

DOI

10.3389/fgene.2025.1715229

Academic Level

faculty

Mentor/PI Department

Medical Education

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.